Bersanlimab (Anti-ICAM1 / CD54)

Ask supplier a question | View on supplier's website

Bersanlimab (Anti-ICAM1 / CD54) is a fully human monoclonal antibody that targets intercellular adhesion molecule-1 (ICAM-1 or CD54). Bersanlimab has anticancer effects. MW: 145.5 KD.

Supplier	Selleck Chemicals
Product #	A2464
Sku #	A2464-1mg*25
Pricing	1mg*25, $4170.00

Feedback